Lymphedema Unknown Status Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00318513Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity LymphedemaTreatment